ClearPoint Neuro (CLPT) EPS (Basic) Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.74% |
| Dec 31, 2025 | -14.88% |
| Sep 30, 2025 | 70.24% |
| Jun 30, 2025 | -13.81% |
| Mar 31, 2025 | -11.10% |
| Dec 31, 2024 | -12.70% |
| Sep 30, 2024 | -17.61% |
| Jun 30, 2024 | -4.24% |
| Mar 31, 2024 | -7.78% |
| Dec 31, 2023 | -11.55% |
| Sep 30, 2023 | -9.00% |
| Jun 30, 2023 | -11.27% |
| Mar 31, 2023 | -8.92% |
| Sep 30, 2021 | 27.84% |
| Jun 30, 2021 | 28.35% |
| Mar 31, 2021 | 31.94% |
| Dec 31, 2020 | 252.24% |
| Sep 30, 2020 | -269.88% |
| Jun 30, 2020 | 41.75% |
| Mar 31, 2020 | -21.06% |
| Dec 31, 2019 | -22.42% |
| Sep 30, 2019 | -10.15% |
| Jun 30, 2019 | -34.08% |
| Mar 31, 2019 | -36.56% |
| Dec 31, 2018 | -29.67% |
| Sep 30, 2018 | -21.06% |
| Jun 30, 2018 | -53.42% |
| Mar 31, 2018 | -49.63% |
| Sep 30, 2016 | -47.90% |
| Jun 30, 2016 | -47.25% |
| Mar 31, 2016 | -44.76% |